Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Field-effect-informed urine liquid biopsy for bladder cancer.

Cell·2026

Same author

Factors influencing the pediatric hospitalization experience: a narrative review with recommendations for improvement.

Translational pediatrics·2025

Same author

High body mass index increases the risk for prostate cancer and high Gleason score in northern Tanzania: data from prostate cancer screening.

Ecancermedicalscience·2025

Same author

Measuring characteristics of wild and cultivated food environments: a scoping review.

BMC medicine·2024

Same author

Mentorship in medical education: reflections on the importance of both unofficial and official mentorship programs.

BMC medical education·2024

Same author

Diverging Trends in Left Without Being Seen Rates During the Pandemic Era: Emergency Department Length of Stay May Be a Key Factor.

The Journal of emergency medicine·2024

Same journal

Robotic excision of a giant seminal vesicle cyst.

Current urology·2026

Same journal

Implantable bladder sensors for real-time urodynamics: A systematic review of preclinical and clinical evidence in neuro-urology.

Current urology·2026

Same journal

The regulatory mechanism and clinical significance of RNA editing in prostate cancer.

Current urology·2026

Same journal

Cancer-specific mortality of grade group 1 prostate cancer: Results from Surveillance, Epidemiology, and End Results Database, 2004-2021.

Current urology·2026

Same journal

Editorial comment on Chinese expert consensus on prostate-pelvic syndrome.

Current urology·2026

Same journal

Role of miR-34a/KLF4 axis in podocyte injury and obesity-related glomerulopathy with preliminary observations in clear cell renal cell carcinoma.

Current urology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 28, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Prostate specific antigen: the past, present and future.

Harcharan Gill¹, Jonathan Wu¹

¹Department of Urology, Stanford University School of Medicine, Stanford, Calif., USA.

Current Urology

|June 12, 2014

Summary

This summary is machine-generated.

Prostate specific antigen (PSA) screening for prostate cancer in healthy men can lead to overdiagnosis and overtreatment. Further evaluation of newer imaging techniques is recommended to balance screening benefits against harms.

Keywords:

Prostate cancer Prostate-specific antigen Screening

More Related Videos

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Related Experiment Videos

Last Updated: Apr 28, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Area of Science:

Urology
Oncology
Diagnostic Imaging

Background:

Prostate cancer screening in asymptomatic men is a subject of ongoing debate.
Prostate-specific antigen (PSA) testing is a primary tool for prostate cancer detection.

Purpose of the Study:

To review current data on the use of PSA for screening healthy men for prostate cancer.
To evaluate the benefits and harms associated with PSA-based prostate cancer screening.

Main Methods:

Comprehensive literature review.
Analysis of guidelines from major health organizations, including the American Cancer Society and American Urologic Association.

Main Results:

Current PSA screening protocols are associated with a high rate of prostate cancer overdiagnosis.
Overdiagnosis frequently leads to unnecessary invasive procedures, such as biopsies, and subsequent treatments.

Conclusions:

The benefits of PSA screening and treatment must be carefully weighed against the harms of overdiagnosis and overtreatment.
Emerging imaging technologies, such as magnetic resonance imaging (MRI), require further investigation to assess their role in improving screening accuracy and reducing unnecessary interventions.